Madrigal is looking to expand its portfolio of products through in-licensing, acquisition, and co-development collaborations targeting both niche and broad indications in the areas of cardiovascular and metabolic diseases. We are open to partnering with companies for the development of our cardiometabolic products.
By focusing on these key therapeutic areas, Madrigal is able to offer a unique collaborative approach for its partners to both develop and commercialize novel, high-value pharmaceuticals that target unmet medical needs in niche and broad indications within cardiovascular and metabolic diseases.
This is a password protected area. If you have been provided a Madrigal Pharmaceuticals’ DataSite login, you may access the DataSite by entering your username and password, leave Project empty. If you would like to learn more about partnering or investment opportunities with Madrigal Pharmaceuticals, please contact us at BD@madrigalpharma.com.